DAISY EDWARDS: Open Payments
NPI 1083954846 · FLOYD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 42 payments from 12 companies in 2025. Trend: 2023 $881 · 2024 $617 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $194 |
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
| Novo Nordisk Inc | 6 | $117 |
| Amgen Inc. | 7 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Alkermes, Inc. | 3 | $61 |
| PFIZER INC. | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: RECORLEV, VRAYLAR, OTEZLA, Ozempic, QULIPTA, VIVITROL, ELIQUIS, BREZTRI.
Industry payments across VA — which companies pay providers there.
